Literature DB >> 19011165

Role of protein kinase Czeta and calcium entry in KCl-induced vascular smooth muscle calcium sensitization and feedback control of cellular calcium levels.

Paul H Ratz1, Amy S Miner.   

Abstract

The degree of tonic force (F) maintenance induced in vascular smooth muscle upon K(+) depolarization with 110 mM KCl can be greatly reduced by inhibition of rhoA kinase (ROCK). We explored the possibility that a protein kinase C (PKC) isotype may also play a role in causing KCl-induced Ca(2+) sensitization. In isometric rings of rabbit artery, the PKC inhibitors, Go-6983 (3-[1-[3-(dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione), GF-109203X (2-[1-(3-dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl) maleimide), and a cell-permeable (myristoylated) pseudosubstrate inhibitor of PKCzeta (PI(PKCzeta)) inhibited KCl-induced tonic F. A myristoylated pseudosubstrate inhibitor of PKCalpha/beta that inhibited phorbol dibutyrate-induced F slightly potentiated KCl-induced tonic F and attenuated 30 mM KCl-induced F. Although the ROCK inhibitor, H-1152 [(S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)-sulfonyl]-hexahydro-1H-1,4-diazepine dihydrochloride], reduced basal phosphorylation of myosin light-chain phosphatase-targeting subunit at Thr853 (MYPT1-pT853), 3 and 10 muM GF-109203X inhibited only KCl-stimulated phosphorylation, not basal MYPT1-pT853. In fura-2-loaded tissues, GF-109203X and PI(PKCzeta) elevated basal [Ca(2+)](i) (calcium) and potentiated KCl-induced tonic increases in calcium while reducing KCl-induced tonic increases in F. Blockade by nifedipine of Ca(2+) entry through voltage-operated Ca(2+) channels reduced KCl-induced Ca(2+) sensitization and KCl-stimulated but not basal MYPT1-pT853. These data together support a model in which ROCK and PKCzeta are constitutively active and function in "resting" muscle to regulate the basal levels of MYPT1-pT853 and calcium, respectively. In this model, KCl-induced increases in calcium activate PKCzeta to feed forward and cause additional MYPT1-pT853 above that induced by constitutive ROCK, permitting Ca(2+) sensitization and strong F maintenance. Active PKCzeta also feeds back to attenuate the degree of KCl-induced increases in calcium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19011165      PMCID: PMC2682280          DOI: 10.1124/jpet.108.142422

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

1.  Constitutively active L-type Ca2+ channels.

Authors:  Manuel F Navedo; Gregory C Amberg; V Scott Votaw; Luis F Santana
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

2.  Evidence for absence of latch-bridge formation in muscular saphenous arteries.

Authors:  Shaojie Han; John E Speich; Thomas J Eddinger; Krystina M Berg; Amy S Miner; Chris Call; Paul H Ratz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-02-03       Impact factor: 4.733

3.  RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells.

Authors:  Huan Pang; Zhenheng Guo; Wen Su; Zhongwen Xie; Masumi Eto; Ming C Gong
Journal:  Am J Physiol Cell Physiol       Date:  2005-04-06       Impact factor: 4.249

Review 4.  Rho kinase: a target for treating urinary bladder dysfunction?

Authors:  Stephan L M Peters; Martina Schmidt; Martin C Michel
Journal:  Trends Pharmacol Sci       Date:  2006-07-25       Impact factor: 14.819

5.  Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells.

Authors:  Andrea Murányi; Dmitry Derkach; Ferenc Erdodi; Andrea Kiss; Masaaki Ito; David J Hartshorne
Journal:  FEBS Lett       Date:  2005-11-09       Impact factor: 4.124

6.  Regulation of Rho/ROCK signaling in airway smooth muscle by membrane potential and [Ca2+]i.

Authors:  Caiqiong Liu; Jianmin Zuo; Evi Pertens; Peter B Helli; Luke J Janssen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-06-03       Impact factor: 5.464

7.  Convergence of Ca2+-desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP.

Authors:  Melissa Porter; Melissa C Evans; Amy S Miner; Krystina M Berg; Kevin R Ward; Paul H Ratz
Journal:  Am J Physiol Cell Physiol       Date:  2006-01-18       Impact factor: 4.249

8.  Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.

Authors:  George J Dimopoulos; Shingo Semba; Kazuyo Kitazawa; Masumi Eto; Toshio Kitazawa
Journal:  Circ Res       Date:  2006-12-07       Impact factor: 17.367

Review 9.  Development of Rho-kinase inhibitors for cardiovascular medicine.

Authors:  Hiroaki Shimokawa; Mamunur Rashid
Journal:  Trends Pharmacol Sci       Date:  2007-05-07       Impact factor: 14.819

10.  Stretch-induced triphosphorylation of myosin light chain and myogenic tone in canine basilar artery.

Authors:  Kazuo Obara; Mayumi Uchino; Masayo Koide; Akihiro Yamanaka; Koichi Nakayama
Journal:  Eur J Pharmacol       Date:  2006-02-23       Impact factor: 4.432

View more
  14 in total

1.  Calcium-independent phospholipase A2 participates in KCl-induced calcium sensitization of vascular smooth muscle.

Authors:  Paul H Ratz; Amy S Miner; Suzanne E Barbour
Journal:  Cell Calcium       Date:  2009-05-31       Impact factor: 6.817

2.  Active tension adaptation at a shortened arterial muscle length: inhibition by cytochalasin-D.

Authors:  Melissa L Bednarek; John E Speich; Amy S Miner; Paul H Ratz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-14       Impact factor: 4.733

3.  Failure of Bay K 8644 to induce RhoA kinase-dependent calcium sensitization in rabbit blood vessels.

Authors:  S M Alvarez; A S Miner; B M Browne; P H Ratz
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Chemerin-induced arterial contraction is Gi- and calcium-dependent.

Authors:  David J Ferland; Emma S Darios; Richard R Neubig; Benita Sjögren; Nguyen Truong; Rosa Torres; Thomas S Dexheimer; Janice M Thompson; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2016-11-24       Impact factor: 5.773

Review 5.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

6.  Rho-kinase inhibition attenuates calcium-induced contraction in β-escin but not Triton X-100 permeabilized rabbit femoral artery.

Authors:  Lyndsay J Clelland; Brendan M Browne; Silvina M Alvarez; Amy S Miner; Paul H Ratz
Journal:  J Muscle Res Cell Motil       Date:  2011-06-25       Impact factor: 2.698

7.  Physiological vs. pharmacological signalling to myosin phosphorylation in airway smooth muscle.

Authors:  Ning Gao; Ming-Ho Tsai; Audrey N Chang; Weiqi He; Cai-Ping Chen; Minsheng Zhu; Kristine E Kamm; James T Stull
Journal:  J Physiol       Date:  2017-08-24       Impact factor: 5.182

8.  Enhanced KCl-mediated contractility and Ca2+ sensitization in porcine collateral-dependent coronary arteries persist after exercise training.

Authors:  Cristine L Heaps; Jeff F Bray; Janet L Parker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-08-28       Impact factor: 4.733

9.  Sealing of transected neurites of rat B104 cells requires a diacylglycerol PKC-dependent pathway and a PKA-dependent pathway.

Authors:  Aleksej Zuzek; Jerry D Fan; Christopher S Spaeth; George D Bittner
Journal:  Cell Mol Neurobiol       Date:  2012-08-03       Impact factor: 5.046

Review 10.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.